Investments
33Portfolio Exits
4Funds
1About Harbor Light Capital Partners
Harbor Light Capital Partners is a private investment firm investing in early and growth stage companies in the technology, healthcare, energy and manufacturing sectors. It makes equity investments in the $1M to $5M range.
Harbor Light Capital Partners Headquarter Location
38 Central Square
Keene, New Hampshire, 03431,
United States
Latest Harbor Light Capital Partners News
Jan 16, 2014
Alcyone Lifesciences nabs $4 mln January 16, 2014 Alcyone Lifesciences has raised $4 million in Series B financing. Edgar D. Jannotta, Jr. led the round with participation from Harbor Light Capital Partners. Based in Concord, Mass., Alcyone Lifesciences develops products that treat neuropathological conditions. PRESS RELEASE CONCORD, MA–(Marketwired – Jan 15, 2014) – Alcyone Lifesciences, Inc., a privately-held medical device company developing products for the treatment of difficult neuropathological conditions, announced the closing of a Series B preferred financing of $4 million with existing and new investors. The financing was led by Edgar D. Jannotta, Jr. and included participation by Harbor Light Capital Partners, both of which were investors in the Company’s prior financings. The funds will be used to support further development of Alcyone’s platform technology for delivery of therapy to the brain as well as a novel technology to manage CSF (cerebrospinal fluid) shunt occlusions. “Having worked with the outstanding team at Alcyone Lifesciences and seen firsthand the progress made to date, I am eager to see the Company’s disruptive technologies brought into the clinic,” said Mr. Edgar Jannotta, Jr. who is also a member of the Board of Director of Alcyone Lifesciences. PJ Anand, Chief Executive Officer of Alcyone Lifesciences, commented, “This funding from our new and existing investors will allow the Company to execute on its next product development activities and clinical and regulatory milestones towards commercialization of our technologies. The additional capital resources, together with our strategic collaborations focused on the field of CNS therapy, leave us well positioned to build on the tremendous progress made in our platform therapeutic delivery technology and to continue the development of our fail-safe CSF management system. The Company is thankful to Mr. Jannotta and our current investor base for their continued support.” Nutter, McClennen & Fish LLP, led by Michelle Basil, represented the Company in the financing. Ms. Basil has represented the Company since its inception. About Alcyone LifeSciences Alcyone Lifesciences, based in Concord, Massachusetts, is a privately-held medical device company focused on development of novel treatment modalities for difficult neurological conditions. Alcyone Lifesciences was founded in 2010 by PJ Anand, CEO, Adam Fleisher, MD., Associate Professor of Neuroscience, UCSD, Banner Alzheimer’s Institute, and William Olbricht, PhD, Professor of Biomedical Engineering, Cornell University. For more information about Alcyone, please visit www.alcyonels.com. © 2015 Buyouts Insider / Argosy Group LLC
Harbor Light Capital Partners Investments
33 Investments
Harbor Light Capital Partners has made 33 investments. Their latest investment was in Alcyone Lifesciences as part of their Series E on September 9, 2020.
Harbor Light Capital Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
9/2/2020 | Series E | Alcyone Lifesciences | $17.55M | No | 1 | |
1/17/2018 | Series D | Alcyone Lifesciences | $5.14M | No | 1 | |
10/3/2017 | Series B - II | Carmell Therapeutics | $1.97M | No | 2 | |
7/11/2017 | Series B | |||||
3/15/2017 | Series B |
Date | 9/2/2020 | 1/17/2018 | 10/3/2017 | 7/11/2017 | 3/15/2017 |
---|---|---|---|---|---|
Round | Series E | Series D | Series B - II | Series B | Series B |
Company | Alcyone Lifesciences | Alcyone Lifesciences | Carmell Therapeutics | ||
Amount | $17.55M | $5.14M | $1.97M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 1 | 2 |
Harbor Light Capital Partners Portfolio Exits
4 Portfolio Exits
Harbor Light Capital Partners has 4 portfolio exits. Their latest portfolio exit was Covetrus on February 08, 2019.
Harbor Light Capital Partners Fund History
1 Fund History
Harbor Light Capital Partners has 1 fund, including Harbor Light Capital Partners Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
12/3/2008 | Harbor Light Capital Partners Fund | Diversified Private Equity | Closed | $30M | 1 |
Closing Date | 12/3/2008 |
---|---|
Fund | Harbor Light Capital Partners Fund |
Fund Type | Diversified Private Equity |
Status | Closed |
Amount | $30M |
Sources | 1 |
Harbor Light Capital Partners Team
3 Team Members
Harbor Light Capital Partners has 3 team members, including current Managing Partner, Todd Warden.
Name | Work History | Title | Status |
---|---|---|---|
Todd Warden | Markem-Imaje, General Catalyst, and Allaire | Managing Partner | Current |
Richard A. Upton | Bear Stearns | General Partner | Current |
Alan Kirshenbaum | TPG, MainStay Investments, Bear Stearns, KPMG, and CohnReznick | Founder | Former |
Name | Todd Warden | Richard A. Upton | Alan Kirshenbaum |
---|---|---|---|
Work History | Markem-Imaje, General Catalyst, and Allaire | Bear Stearns | TPG, MainStay Investments, Bear Stearns, KPMG, and CohnReznick |
Title | Managing Partner | General Partner | Founder |
Status | Current | Current | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.